Rate of neurotoxicant exposure determines morphologic manifestations of distal axonopathy

R M LoPachin1, E J Lehning, L A Opanashuk

  • 1Department of Anesthesiology, Albert Einstein College of Medicine/Montefiore Medical Center, 111 E. 210th Street, Bronx, New York, 10467-2490, USA. lopachin@aecom.yu.edu

Insights

Chemicals can cause nerve damage called distal axonopathy. Recent research suggests that nerve swelling and degeneration may be nonspecific, questioning their relevance in neurotoxicity assessment.

Area of Science:

  • Neuroscience
  • Toxicology
  • Pathology

Background:

  • Chemical exposures (agricultural, industrial, pharmaceutical) can cause central-peripheral distal axonopathy.
  • This nerve damage is morphologically characterized by distal axon swellings and secondary degeneration.
  • Significant research has focused on the molecular mechanisms of these neuropathic features.

Purpose of the Study:

  • To review evidence for dose-related dependency in distal axonopathies.
  • To discuss the implications of this dose-dependency for understanding chemical-induced neurotoxicity.

Main Methods:

  • Review of existing research on neurotoxicant exposure and distal axonopathies.
  • Analysis of the relationship between exposure rates (mg/kg/day) and observed neuropathic features.
  • Discussion of the pathophysiological relevance of axon swelling and degeneration.

Main Results:

  • Recent studies indicate axon swelling and degeneration may correlate with subchronic low-dose exposure rates.
  • These morphological changes might not be directly linked to neurophysiological deficits or behavioral toxicity.
  • The relevance of these phenomena as specific indicators of neurotoxicity is questioned.

Conclusions:

  • Distal axonopathies might be nonspecific phenomena, dependent on exposure rates rather than specific molecular mechanisms.
  • This challenges current understanding of neurotoxicity mechanisms, biomarker development, and risk assessment models.
  • Re-evaluation of toxic neuropathies' diagnosis and treatment may be necessary based on dose-dependency.

Related Concept Videos

Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Botulism01:22

Botulism

Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Secondary Spinal Cord Injury llI: Pathophysiology01:25

Secondary Spinal Cord Injury llI: Pathophysiology

Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...